- Report
- September 2024
- 296 Pages
Global
From €3842EUR$4,197USD£3,265GBP
- Report
- April 2025
- 381 Pages
Global
From €3842EUR$4,197USD£3,265GBP
- Report
- November 2024
- 350 Pages
Global
From €3657EUR$3,995USD£3,108GBP
- Newsletter
- May 2025
Global
€2742EUR$2,995USD£2,330GBP
- Report
- January 2020
- 508 Pages
Global
From €4485EUR$4,899USD£3,811GBP
- Report
- March 2023
- 139 Pages
Global
From €2289EUR$2,500USD£1,945GBP
- Report
- June 2021
- 142 Pages
Global
From €2517EUR$2,750USD£2,139GBP
€5035EUR$5,500USD£4,279GBP
- Report
- January 2024
- 121 Pages
Global
From €4257EUR$4,650USD£3,618GBP
- Report
- September 2022
- 115 Pages
Global
From €6866EUR$7,500USD£5,835GBP
- Report
- March 2024
- 200 Pages
Global
From €3799EUR$4,150USD£3,229GBP
- Report
- May 2022
- 240 Pages
Global
From €4074EUR$4,450USD£3,462GBP
- Report
- September 2020
- 700 Pages
Global
From €4485EUR$4,900USD£3,812GBP
- Report
- March 2024
- 103 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Book
- August 2014
- 240 Pages
- Book
- June 2017
- 424 Pages
- Book
- April 2013
- 320 Pages
- Book
- April 2013
- 584 Pages
- Book
- November 2008
- 288 Pages
- Book
- April 2013
- 778 Pages

Progenitor cells are a type of stem cell that have the potential to differentiate into a variety of specialized cell types. They are used in biotechnology for a variety of applications, including regenerative medicine, drug discovery, and tissue engineering. Progenitor cells are typically derived from adult tissue, such as bone marrow, and are used to create cell lines for research and therapeutic purposes.
The progenitor cell market is a rapidly growing sector of the biotechnology industry. Companies in this market are focused on developing and commercializing products and services related to progenitor cells, such as cell lines, cell culture media, and cell-based assays. These products and services are used by researchers and pharmaceutical companies to develop new treatments and therapies.
Some companies in the progenitor cell market include Thermo Fisher Scientific, Merck KGaA, Lonza, and STEMCELL Technologies. Show Less Read more